The goal of this clinical trial is to learn if an integrated digital and telemedicine care model works to manage decompensated cirrhosis in patients. It will also learn about the impact of this model on healthcare resource consumption and patient quality of life. The main questions it aims to answer are:
1. Does this telemedicine model lower the number of cirrhosis-related hospitalizations and emergency department visits? 2. Does the model reduce medical expenses and improve disease outcomes compared to standard care?
Researchers will compare the digital telemedicine care model (utilizing the NTUH-TPC platform and wearable devices) to standard health care to see if the digital approach effectively reduces hospital admissions and medical costs.
Participants will:
1. Use the NTUH telehealth platform (NTUH-TPC) to access records and upload physiological, medical, and imaging data. 2. Wear a smart watch for remote physiological monitoring. Receive continuous remote care and proactive follow-ups from case managers.
Patients with decompensated cirrhosis and a Child score of B or C
Age: 18 years or older
Must return for a follow-up visit at least every 3 months
Patients with active malignant tumors (those with a history of malignant tumors must have been cured for at least 2 years)
Patients with an expected survival of less than one year
Parallel
Telemedicine care
Device1. NTUH telehealth platform for cirrhosis, NTUH-TPC 2. Provide a wearable device (Asus vivowatch 6 aero) 3. Telemonitoring by case manager 4. Self-reported information from enrolled patients
Change in Liver Disease Severity Scores
MELD 3.0 score
Rate of All-Cause Unplanned Hospitalizations
It measures how frequently participants are admitted to the hospital for any unexpected medical reason over a 12-month period.
Rate of All-Cause Unplanned Emergency Room Visits
The study tracks every instance a participant visits the Emergency Room (ER) for an unscheduled medical issue over a 12-month period.
Days alive and out of hospital
This metric is a patient-centered outcome used to measure the total amount of time a participant spends healthy and at home, rather than in a hospital or losing life due to disease.
Quality of Life Score & Patient Satisfaction
This composite metric measures how the clinical trial's care models affect the daily well-being, emotional state, and overall happiness of patients living with advanced liver disease. By using thise two questionnaries "CLDQ" and "EQ-5D-5L".
Click on the lead sponsor to view all of their trials.
National Taiwan University Hospital
Lead sponsor
National Science and Technology Council, Taiwan
Collaborator
This trial is not recruiting at the moment. You can still explore other options:
